The effects of experimental, meteorological, and physiological factors on short-term repeated pulse wave velocity measurements, and measurement difficulties: A randomized crossover study with two devices.

carotid-femoral pulse wave velocity experimental conditions measurement difficulty measurement error meteorological conditions predictors pulse wave velocity within subject variation

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 14 07 2022
accepted: 21 12 2022
entrez: 30 1 2023
pubmed: 31 1 2023
medline: 31 1 2023
Statut: epublish

Résumé

Large longitudinal studies with repeated pulse wave velocity (PWV) measurements, a direct measure of arterial stiffness, are required to realize the full potential of arterial stiffness in clinical practice. To facilitate such studies it is important to increase the power of a study by reducing within-subject variability of PWV, and to ease the use of a PWV device in clinical settings by minimizing PWV measurement difficulties. We systematically investigated experimental setting and meteorological conditions, as well as physiological factors and participant characteristics, to determine whether and to what extent they affected: between- and within-subjects variability of PWV recordings, and measurement difficulties of a particular device. We conducted a 2-week longitudinal block-randomized cross-over study with two blinded observers and two commonly used devices: applanation tonometry SphygmoCor CvMS and oscillometric Arteriograph to assess carotid-femoral (cfPWV) or aortic (PWVao) PWV, respectively. Our sample had uniform and wide-spread distribution of age, blood pressures, hypertensive status and BMI. Each participant ( In addition to age and mean arterial pressure (MAP) that strongly affected both cfPWV and PWVao, other significant factors appeared to indicate a measurement approach. cfPWV as a more direct measure of arterial stiffness was additionally affected by hypertension status, outdoor temperature, interaction of MAP with outdoor temperature and the order of visit, with MAP within-subject variability contributing on average 0.27 m/s to difference in repeated measurements at 5 We identified factors affecting PWV recordings and measurement-difficulties and propose how to improve PWV measuring protocols.

Sections du résumé

Background UNASSIGNED
Large longitudinal studies with repeated pulse wave velocity (PWV) measurements, a direct measure of arterial stiffness, are required to realize the full potential of arterial stiffness in clinical practice. To facilitate such studies it is important to increase the power of a study by reducing within-subject variability of PWV, and to ease the use of a PWV device in clinical settings by minimizing PWV measurement difficulties.
Methods UNASSIGNED
We systematically investigated experimental setting and meteorological conditions, as well as physiological factors and participant characteristics, to determine whether and to what extent they affected: between- and within-subjects variability of PWV recordings, and measurement difficulties of a particular device. We conducted a 2-week longitudinal block-randomized cross-over study with two blinded observers and two commonly used devices: applanation tonometry SphygmoCor CvMS and oscillometric Arteriograph to assess carotid-femoral (cfPWV) or aortic (PWVao) PWV, respectively. Our sample had uniform and wide-spread distribution of age, blood pressures, hypertensive status and BMI. Each participant (
Results UNASSIGNED
In addition to age and mean arterial pressure (MAP) that strongly affected both cfPWV and PWVao, other significant factors appeared to indicate a measurement approach. cfPWV as a more direct measure of arterial stiffness was additionally affected by hypertension status, outdoor temperature, interaction of MAP with outdoor temperature and the order of visit, with MAP within-subject variability contributing on average 0.27 m/s to difference in repeated measurements at 5
Conclusion UNASSIGNED
We identified factors affecting PWV recordings and measurement-difficulties and propose how to improve PWV measuring protocols.

Identifiants

pubmed: 36712242
doi: 10.3389/fcvm.2022.993971
pmc: PMC9873998
doi:

Types de publication

Journal Article

Langues

eng

Pagination

993971

Informations de copyright

Copyright © 2023 Podrug, Šunjić, Bekavac, Koren, Đogaš, Mudnić, Boban and Jerončić.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hypertens Res. 2013 Mar;36(3):208-12
pubmed: 23034469
J Appl Physiol (1985). 2006 Apr;100(4):1210-4
pubmed: 16223975
Circulation. 2006 Feb 7;113(5):657-63
pubmed: 16461838
Behav Res Ther. 2017 Nov;98:19-38
pubmed: 28577757
J Am Coll Cardiol. 2005 Nov 1;46(9):1753-60
pubmed: 16256881
Front Cardiovasc Med. 2022 Mar 01;9:821568
pubmed: 35299977
J Hypertens. 2020 Aug;38(8):1531-1540
pubmed: 32195822
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623
Vascular. 2012 Dec;20(6):342-9
pubmed: 22962046
Hypertension. 2002 Mar 1;39(3):735-8
pubmed: 11897754
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
J Hypertens. 2009 Aug;27(8):1624-30
pubmed: 19531964
J Hypertens. 2009 Dec;27(12):2351-7
pubmed: 19915482
Hypertension. 2004 Jun;43(6):1239-45
pubmed: 15123572
Angiology. 2018 Aug;69(7):617-629
pubmed: 29172654
Hypertension. 2016 Jul;68(1):236-42
pubmed: 27245180
Pulse (Basel). 2014 May;2(1-4):11-7
pubmed: 26587439
Hypertension. 2013 Dec;62(6):982-7
pubmed: 24041952
Hypertension. 2013 Apr;61(4):908-14
pubmed: 23381792
Hypertension. 2003 Nov;42(5):915-8
pubmed: 12975386
J Hypertens. 2012 Jul;30(7):1444-52
pubmed: 22573124
Educ Psychol Meas. 2018 Oct;78(5):737-761
pubmed: 32655168
J Hypertens. 1998 Dec;16(12 Pt 2):2079-84
pubmed: 9886900
BMC Cardiovasc Disord. 2021 Jan 13;21(1):33
pubmed: 33441117
Scand J Clin Lab Invest. 2014 Mar;74(2):155-62
pubmed: 24329101
J Hypertens. 2007 Apr;25(4):827-31
pubmed: 17351375
J Am Coll Cardiol. 2019 Sep 3;74(9):1237-1263
pubmed: 31466622
Hypertension. 2010 Aug;56(2):217-24
pubmed: 20566959
PLoS One. 2017 Feb 23;12(2):e0172550
pubmed: 28231259
J Hypertens. 2003 Mar;21(3):487-90
pubmed: 12640237
J Hypertens. 2007 Feb;25(2):383-9
pubmed: 17211245
Hypertens Res. 2014 Jan;37(1):64-8
pubmed: 24048486
J Hum Hypertens. 2007 Feb;21(2):141-8
pubmed: 17136108
Hypertens Res. 2008 Apr;31(4):607-13
pubmed: 18633171
Front Cardiovasc Med. 2018 Jun 11;5:64
pubmed: 29951487
J Hypertens. 2013 May;31(5):940-5
pubmed: 23337470
Clin Exp Hypertens. 1996 Apr-May;18(3-4):347-62
pubmed: 8743026
Hypertens Res. 2013 Aug;36(8):711-7
pubmed: 23486167
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27
pubmed: 20338492
Hypertens Res. 2011 Feb;34(2):202-8
pubmed: 20962783
Hypertension. 2015 Sep;66(3):698-722
pubmed: 26160955
J Hypertens. 2013 May;31(5):946-51
pubmed: 23511340
Front Cardiovasc Med. 2020 Oct 29;7:544302
pubmed: 33330638
J Hypertens. 2017 Dec;35(12):2436-2442
pubmed: 28719470
J Hum Hypertens. 2009 Sep;23(9):597-604
pubmed: 19242493
J Hypertens. 2009 Nov;27(11):2186-91
pubmed: 19834344
J Hypertens. 2010 Oct;28(10):2068-75
pubmed: 20651604
Hypertension. 2021 Sep;78(4):983-995
pubmed: 34455813
Hypertens Res. 2014 Nov;37(11):999-1007
pubmed: 25056681
Med Sci Monit. 2010 Jun;16(6):CR301-6
pubmed: 20512094
Am J Hypertens. 2016 Apr;29(4):470-5
pubmed: 26232036
Hypertension. 2001 Oct;38(4):949-52
pubmed: 11641315
J Hypertens. 2018 Nov;36(11):2204-2214
pubmed: 29846328
Clin Exp Hypertens. 2019;41(7):670-674
pubmed: 30409046
J Clin Hypertens (Greenwich). 2011 Jan;13(1):19-22
pubmed: 21214717
J Hypertens. 2014 Aug;32(8):1577-9
pubmed: 24991791
Am J Hypertens. 2017 Dec 8;31(1):80-88
pubmed: 29059329
Hypertension. 2019 Aug;74(2):218-228
pubmed: 31203728
Circ Res. 2021 Apr 2;128(7):864-886
pubmed: 33793325
J Appl Physiol (1985). 2013 Dec;115(11):1610-7
pubmed: 24052034
Hypertension. 2009 Dec;54(6):1328-36
pubmed: 19884567
Am J Hypertens. 2011 Sep;24(9):970-5
pubmed: 21544148
Hypertens Res. 2004 Nov;27(11):851-7
pubmed: 15824467
J Hypertens. 2012 Jul;30(7):1383-91
pubmed: 22688260
Arthritis Rheum. 2004 Feb;50(2):581-8
pubmed: 14872502
J Am Coll Cardiol. 2014 Feb 25;63(7):636-646
pubmed: 24239664
Am J Epidemiol. 2016 Jun 1;183(11):1071-3
pubmed: 27188937
Int J Cardiol Heart Vasc. 2020 Aug 05;30:100598
pubmed: 32793802
Arterioscler Thromb Vasc Biol. 2004 May;24(5):969-74
pubmed: 15001456
Front Cardiovasc Med. 2020 Apr 28;7:72
pubmed: 32411729
J Clin Hypertens (Greenwich). 2017 Jan;19(1):6-10
pubmed: 27677467
Hypertension. 2002 Jun;39(6):1083-7
pubmed: 12052846
Circulation. 2010 Feb 2;121(4):505-11
pubmed: 20083680
J Hypertens. 2004 Jul;22(7):1317-22
pubmed: 15201547
Eur Heart J. 2010 Oct;31(19):2338-50
pubmed: 20530030
J Hypertens. 2008 Jul;26(7):1411-9
pubmed: 18551018

Auteurs

Mario Podrug (M)

Laboratory of Vascular Aging, University of Split School of Medicine, Split, Croatia.
University Department of Health Studies, University of Split, Split, Croatia.

Borna Šunjić (B)

Laboratory of Vascular Aging, University of Split School of Medicine, Split, Croatia.
University Department of Health Studies, University of Split, Split, Croatia.

Anamarija Bekavac (A)

PhD Study Programme, University of Split School of Medicine, Split, Croatia.

Pjero Koren (P)

Laboratory of Vascular Aging, University of Split School of Medicine, Split, Croatia.
Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.

Varja Đogaš (V)

Department of Psychological Medicine, University of Split School of Medicine, Split, Croatia.

Ivana Mudnić (I)

Department of Basic and Clinical Pharmacology, University of Split School of Medicine, Split, Croatia.

Mladen Boban (M)

Department of Basic and Clinical Pharmacology, University of Split School of Medicine, Split, Croatia.

Ana Jerončić (A)

Laboratory of Vascular Aging, University of Split School of Medicine, Split, Croatia.
Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.

Classifications MeSH